Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy-Reference-Cited by-同舟云学术

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy

Published:2006-01 Issue:1 Volume:17 Page:131-134
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ghavamzadeh A.,Alimoghaddam K.,Ghaffari S.H.,Rostami S.,Jahani M.,Hosseini R.,Mossavi A.,Baybordi E.,Khodabadeh A.,Iravani M.,Bahar B.,Mortazavi Y.,Totonchi M.,Aghdami N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/1/131/379849/mdj019.pdf

Reference27 articles.

1. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol;Tallman;Blood,2002

2. All transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases;Fenaux;Blood,1992

3. Multi-institutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia;Ohno;Leukemia,1993

4. Alltrans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia;Kanamaru;Blood,1995

5. Molecular remission in PML-RAR positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy;Mandelli;Blood,1997

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Regulation of the Glucose Transporter GLUT3 in PRDX1 Null Cells Caused Hypersensitivity to Arsenite;Cells;2023-11-22

2. Combination Effect of Deferoxamine and Arsenic Trioxide on Viability and Vitality of APL Like Cell Line;ETHIOP J HEALTH SCI;2023

3. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients;Leukemia Research;2023-05

4. Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy;Clinical and Experimental Medicine;2023-04-24

5. Realgar and arsenene nanomaterials as arsenic-based anticancer agents;Current Opinion in Chemical Biology;2023-02